2026-04-01-A-share Market Review: Deep Dive 20260401

📊 Market Snapshot

• SSE Composite Index: 3948.55 (+1.46%)

• Total Market Turnover: 2,012.451 billion CNY

• Advance/Decline Ratio: 4495 / 887

• Limit-up / Limit-down / Limit-up Failure Counts: 56 / 6 / 38

🔍 Top 20 Stocks by Turnover

🏆 Concept Sector Analysis

Top 5 Concept Sectors (by Gain)

Top-Gaining Stocks in Each Sector

Recombinant Protein

CRO

CAR-T Cell Therapy

Innovative Drugs

CPO Concept

💥 Limit-up Stocks

💔 Limit-up Failure Stocks

🚀 Top Traders List (Dragon-Tiger List)

⭐ Key Stock Watchlist

Significant Turnover Anomaly Pool

Momentum Limit-up Watchlist

🤖 AI Deep Analysis and Insights

{ “title”: “Trillion-Yuan Turnover Drives Soaring Market Sentiment, Structural Divergence and Opportunities Led by Pharma and AI Dual Engines”, “tags”: [“Soaring Market Sentiment”, “Pharmaceuticals & Biotechnology”, “AI Concept”, “CPO”, “Structural Market Trend”], “content”: “## 1. Market Sentiment Diagnosis\n\nToday, the market showed strong performance, with the SSE Composite Index rising 1.46%, and total market turnover exceeding the 2 trillion CNY mark, reaching 2,012.451 billion CNY. This indicates a significant increase in market liquidity. The advance/decline ratio was as high as 4495:887, a nearly 5:1 ratio, suggesting broad-based gains and widespread profit-making opportunities. There were 56 limit-up stocks and 6 limit-down stocks, indicating an overall bullish sentiment. However, 38 limit-up failure stocks suggest strong profit-taking pressure at high levels. With a limit-up failure rate of nearly 40%, it indicates intense market competition and divergence even amidst positive sentiment.\n\nThe current market phase is defined as: broad-based gains with increased volume coexisting with high-level divergence.\n\n- Profitability: Widespread and strong, particularly concentrated in hot sectors such as Pharmaceuticals & Biotechnology and CPO. Consecutive limit-up streaks reached higher tiers, indicating strong investor willingness to chase hot themes.\n- Loss-taking: Primarily observed in limit-up failure stocks, where some high-valuation stocks experienced rapid profit-taking during the trading day. For example, Demingli, a stock with significant turnover, experienced a limit-up failure and closed down, signaling the risks of blindly chasing highs or entering non-mainstream, high-valuation stocks.\n\n## 2. Core Themes and Capital Flows\n\nFrom the [Top 20 by Turnover] and [Sector Performance Rankings], capital flows showed high concentration and clear rotation:\n\n- Hot Sectors (Theme-driven Speculation): Pharmaceuticals & Biotechnology (Recombinant Protein, CRO, CAR-T Cell Therapy, Innovative Drugs) was the strongest core theme today, with the top four gaining sectors all being pharmaceutical concepts, and multiple stocks achieving a 20% limit-up. Second, the CPO concept, representing the AI industry chain, maintained extremely high popularity, with core CPO stocks like Tianfu Communications and Yongding Co. seeing huge turnover and hitting limit-up.\n- Large-cap Resilience Sectors (Index-supporting Blue Chips): Among the top twenty by turnover, in addition to pharmaceuticals and AI, some non-ferrous metals (Zijin Mining, CMOC) and power equipment (Dongfang Electric) also showed active performance, though their gains were not as strong as theme stocks. Blue-chip stocks like CATL and Foxconn Industrial Internet performed relatively steadily, providing support for the index.\n\nMarket Style Assessment: Today’s market style was primarily theme-driven speculation, with two core themes, Pharmaceuticals & Biotechnology and AI (especially CPO), attracting massive capital and leading market sentiment. Simultaneously, the activity of some blue-chip stocks also played a role in supporting the index.\n\n## 3. Consecutive Limit-up Ladder and Spatial Dynamics\n\n- Highest Consecutive Limit-up (Space Limit-up): Tianjin Pharma (600488) reached 4 consecutive limit-ups over 4 days, becoming the highest-tier stock, further reinforcing the strong position of the pharmaceutical sector.\n- Consecutive Limit-up Ladder: The market’s consecutive limit-up ladder is relatively healthy, with 2-day consecutive limit-ups (Star H&C, Tongda Co., JOINN Labs, Xinzhonggang) and numerous strong first limit-ups. Among them, pharmaceutical and AI concept stocks like RZPM, GuangShengTang, EdiPharm, and Zhilifang showed extremely high market recognition with 20% limit-ups.\n- Limit-up Failure Pool Interpretation:\n - Demingli (001309): Experienced a limit-up failure with high turnover and closed down, indicating significant profit-taking pressure at high levels. This is a typical high-level deceleration signal and weighs on sentiment in the semiconductor/storage sector.\n - Watsons (002082): As a former high-flying speculative stock, it failed to maintain its limit-up but still closed with a 9.93% gain. This indicates intense capital competition at high levels and significant risk in chasing highs, signaling a high-level deceleration and divergence.\n - Raisecom (603803): A CPO concept stock that failed limit-up 5 times during the day but ultimately closed with a 9.97% gain, with a turnover rate as high as 20.04%. This indicates extremely intense long-short competition, but bullish forces ultimately prevailed, representing a strong limit-up after constructive divergence and showing strong capital absorption capacity within the sector.\n - Lianhuan Pharma (600513): A pharmaceutical stock that failed limit-up but still had an 8.37% gain, indicating that some capital attempted to take over, but absorption capacity was insufficient. If it stabilizes the next day, it still has potential for a reversal, representing a constructive divergence after divergence.\n\n## 4. Key Anomaly Stock Analysis\n\n1. Tianfu Communications (300394): One of the core leading stocks in the CPO concept, with a daily gain of +10.52% and turnover of 13.680 billion CNY. Benefiting from the sustained high prosperity in AI computing infrastructure construction, capital continues to flock to it. The underlying logic is expected to be the increasing prosperity of the AI industry and performance growth expectations driven by technological leadership.\n2. Yongding Co. (600105): Hit limit-up with a turnover of 6.973 billion CNY, belonging to the telecommunications equipment and CPO concept. Its huge turnover and limit-up may be due to the high prosperity of CPO and its own advantages in communication optoelectronics, possibly combined with catalysts from “UHV/Smart Grid” or other implicit concepts, representing a technical breakthrough driven by the confluence of multiple themes.\n3. WuXi AppTec (603259): Gained +5.82% with a turnover of 8.034 billion CNY, a leading stock in the CRO concept. In the overall rebound of the Pharmaceuticals & Biotechnology sector, its rise as an industry-leading enterprise reflects the market’s trend-following capital allocation logic driven by restored confidence in the CRO and innovative drug sectors.\n4. RZPM (300149): Achieved a 20% limit-up with a turnover of 835.00 million CNY, combining multiple hot themes such as recombinant protein, CRO, innovative drugs, and CAR-T cell therapy. Its limit-up reflects a strong demand for oversold rebound and catch-up in stocks with multiple cutting-edge biotechnological themes within the overall rebound of the pharmaceutical sector.\n\n## 5. Next Day Trading Strategy Recommendations\n\nObservation Points:\n- Potential Reversal Sectors/Stocks: Focus on pharmaceutical & biotechnology stocks that experienced limit-up failures today but still closed with significant gains, such as Lianhuan Pharma, or CPO concept stocks that stabilized after high-level volatility. If these stocks can quickly recover their limit-up failure gap, it may indicate strong capital absorption capacity.\n- Risk of Further Decline in High-Valuation Stocks: Closely monitor stocks that have seen continuous large gains and experienced high-volume limit-up failures, especially high-valuation stocks like Demingli. Be wary of concentrated profit-taking and prevent further decline risks.\n- Signs of New Theme Rotation: Pay attention to whether other sectors with low valuations, improved earnings, or positive policy expectations begin to show anomalies, such as consumer electronics or other sub-sectors of semiconductors.\n\nOverall Strategy: Market liquidity is sufficient, and sentiment is generally warm, but the high limit-up failure rate indicates intensified short-term speculation. Investors are advised to maintain an active participation stance but should focus on highly recognizable leading stocks in core themes, avoiding blindly chasing highs. For stocks with excessive short-term gains, consider taking profits on rallies to secure gains.\n\nKey Stock Trading Recommendations:\n- Tianfu Communications, Yongding Co.: Continue to hold for now. If there is a modest pullback tomorrow, consider small-position dips, but closely monitor volume changes. Once signs of high volume with stagnating gains or clear topping signals appear, partial profit-taking is recommended.\n- WuXi AppTec: As a core allocation stock, it can be held. Its steady rise has a positive impact on market sentiment, but its short-term explosive power is limited.\n- RZPM: This stock has high elasticity. If it opens strongly higher or continues to rise with increased volume tomorrow, cautiously speculate in the short term; if the opening is lower than expected or it rapidly pulls back, it is advisable to wait and see or avoid chasing highs.\n- Demingli: Given its high-level limit-up failure and closing down today, there is short-term downward pressure. It is advisable to wait and see or avoid.\n” }

Note:

1. Data Source: AKShare.
2. This article is AI-assisted and aims to provide market insights and data analysis, not investment advice.
3. Disclaimer: Investment carries risks, so be cautious when entering the market. The content of this article is for reference only and does not constitute any investment advice or recommendation. Please make independent judgments based on your own circumstances.